Charleston, SC -- (SBWIRE) -- 08/30/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Obscene Jeans Corp. (OTCBB:OBJE), Arch Therapeutics Inc (OTCBB:ARTH), OncoSec Medical Inc (OTCMKTS:ONCS), DoMark International Inc (OTCMKTS:DOMK)
Obscene Jeans Corp. (OTCBB:OBJE) increased +12.73% and closed at $0.540 on a traded volume of 242,455 shares, in comparison to 200,416 shares of average trading volume. So far this year, the stock is down over -74.88%.
The company has a total market capitalization of $6.15 million. OBJ Enterprises, Inc., a development stage company, focuses to design, develop, manufacture, market, wholesale, distribute, and sell a women’s line of Obscene Brand jeans.
Why Should Investors Buy OBJE After The Recent Gain? Just Go Here and Find Out
Arch Therapeutics Inc (OTCBB:ARTH) soared +5.19% and closed at $0.385 on a traded volume of 201,087 shares, whereas its average trading volume is 1.16 million shares. In the last three months, the stock is down -93.58%. The Intra-day range for the stock is $0.37 and $0.38.
Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding.
Will ARTH Continue To Move Higher? Find Out Here
OncoSec Medical Inc (OTCMKTS:ONCS) dropped down -2.33% and closed at $0.293. So far in three months, the stock is down -3.59%. The 52-week range for the stock is $0.18 and $0.49 and during the previous trading session the stock touched its highest price at $0.30. Its introductory price for the day was $0.30, with the overall traded volume of 360,064 shares.
OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
Has ONCS Found The Bottom And Ready To Gain Momentum? Find Out Here
DoMark International Inc (OTCMKTS:DOMK), after opening its shares at the price of $0.06, dropped -12.00% to close at $0.0550 for the day. The stock moved on a traded volume of 980,984 shares, in comparison to 265,228 shares of average trading volume.
The 52-week range for the stock is $0.03 and $0.76 and during the previous trading session the stock touched its highest price at $0.06. Its introductory price for the day was $0.06. DoMark International, Inc., a marketing and management company, engages in owning, developing, and marketing various patented game changing consumer products.
Will DOMK Get Buyers Even After The Recent Rally? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)